There are at least 10,000 known monogenic diseases. When attempting to cure them, how do clinicians decide which gene-therapy delivery method is best?| www.asimov.press
Since the Food and Drug Administration first (FDA) began approving commercial applications of CAR-T and CRISPR cell and gene-based therapies (CGT) over the last six years, there has been a growing…| Penn LDI
Despite a recent safety warning from the FDA, companies such as BMS and J&J stress that the benefits of their cancer therapies still outweigh the risks.| PharmaVoice